Clinical Use Case Underscores Cagent Vascular’s Below-the-Knee Therapy Potential

According to a recent LinkedIn post from Cagent Vascular Inc, an interventional case using the company’s Serranator balloon in Serration Remodeling Therapy was featured for treating critical limb ischemia. The case involved below-the-knee disease with gangrene affecting multiple toes, where stepwise endovascular treatment was used to restore blood flow.

The post highlights the use of laser atherectomy followed by a 3.0 x 40 mm Serranator balloon, reportedly achieving full expansion and no residual stenosis on final angiography. For investors, this case example may underscore real-world adoption of Cagent Vascular’s technology in complex limb salvage settings, potentially supporting its value proposition in the peripheral artery disease treatment market.

By emphasizing successful luminal gain in the posterior tibial artery, the content suggests clinical utility in challenging below-the-knee lesions, a segment of growing interest in endovascular therapy. If such outcomes are replicated broadly and translated into stronger clinical evidence and physician uptake, Cagent Vascular could enhance its competitive position and pricing power within the vascular device space.